Luis Ulisses Signori

Luis Ulisses Signori

Auto-generated profile, based on publicly available information

Luis Ulisses Signori

Universidade Federal de Santa Maria

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
ANAngélica Trevisan De Nardi
Angélica Trevisan De Nardi
TTTainara Tolves
Tainara Tolves
TLThatiane Larissa Lenzi
Thatiane Larissa Lenzi
LSLuis Ulisses Signori
Luis Ulisses Signori
ASAntônio Marcos Vargas da Silva
Antônio Marcos Vargas da Silva

11 March 2020 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
NRNatiele Camponogara Righi
Natiele Camponogara Righi
FSFELIPE BARRETO SCHUCH
FELIPE BARRETO SCHUCH
ANAngélica Trevisan De Nardi
Angélica Trevisan De Nardi
CPCaroline Montagner Pippi
Caroline Montagner Pippi
GRGeovana de Almeida Righi
Geovana de Almeida Righi
LSLuis Ulisses Signori
Luis Ulisses Signori

1 June 2012 in Clinics
Verified
Journal Article
Open access
LKLeandro de Moraes Kohl
Leandro de Moraes Kohl
LSLuis Ulisses Signori
Luis Ulisses Signori
RRRodrigo Antonini Ribeiro
Rodrigo Antonini Ribeiro
ASAntonio Marcos Vargas Silva
Antonio Marcos Vargas Silva
PMPaulo Ricardo Moreira
Paulo Ricardo Moreira
RPRodrigo Della Méa Plentz
Rodrigo Della Méa Plentz
The six-minute walk test has been widely used to evaluate functional capacity and predict mortality in several populations. Thus, the aim of this study was to evaluate the prognostic value of the six-minute walk test for the life expectancy of end-stage renal disease patients. Patients over 18 years old who underwent hemodialysis for at least six months were included. Patients with hemodynamic instability, smoking, chronic obstructive pulmonary disease, physical incapacity and acute myocardial stroke in the preceding three months were excluded. Fifty-two patients (54% males; 36+11 years old) were followed for 144 months. The distance walked in the six-minute walk test was a survival predictor for end-stage renal disease patients. In the multivariate analysis, for each 100 meters walked with a 100-meter increment, the hazard ratio was 0.53, with a 95% confidence interval of 0.37-0.74. There was a positive correlation between the distance walked in the six-minute walk test and peak oxygen consumption (r = 0.508). In the multivariate analysis, each year of dialysis treatment represented a 10% increase in death probability; in the severity index analysis, each point on the scale represented an 11% increase in the death risk. We observed that survival increased approximately 5% for every 100 meters walked in the six-minute walk test, demonstrating that the test is a viable option for evaluating the functional capacity in patients with end-stage renal disease.

1 September 2022 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
MMMariana Brondani de Mello
Mariana Brondani de Mello
NRNatiele Camponogara Righi
Natiele Camponogara Righi
FSFelipe Barreto Schuch
Felipe Barreto Schuch
LSLuis Ulisses Signori
Luis Ulisses Signori
ASAntônio Marcos Vargas da Silva
Antônio Marcos Vargas da Silva

1 December 2009 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
GSGraciele Sbruzzia
Graciele Sbruzzia
RRRodrigo A. Ribeiro
Rodrigo A. Ribeiro
BSBeatriz Schaan
Beatriz Schaan
LSLuis U. Signori
Luis U. Signori
ASAntônio M.V. Silva
Antônio M.V. Silva
RPRodrigo D.M. Plentz
Rodrigo D.M. Plentz
Functional electrical stimulation (FES) produces beneficial effects in the treatment of patients with chronic heart failure (CHF), but studies carried out in these patients show small sample sizes and conflicting results. The aim of this meta-analysis was to systematically review the effect of treatment with FES compared with conventional aerobic exercise training (CA) or control group in patients with CHF. The search strategy included MEDLINE, LILACS, Physiotherapy Evidence Database and Cochrane Library. Randomized trials comparing FES versus CA or control group in the treatment of patients with CHF were included. Two reviewers independently extracted the data. Main analysis used a fixed-effects model. The search retrieved 794 articles, from which seven studies were included. Treatment with FES provided a smaller gain in peak VO2 compared with CA {-0.74 ml/kg per min [95% confidence interval (CI): -1.38 to -0.10]}. There was no difference in the muscle strength [-0.33 Nm (95% CI: -4.56 to 3.90)] and in the distance of the 6-min walk test [2.73 m (95% CI: -15.39 to 20.85)] on comparing FES with CA. An increase in peak VO2 of 2.78 ml/kg per min (95% CI: 1.44-4.13) was observed in FES versus the control group. Treatment with FES provides a similar gain in the distance of the 6-min walk test and in the muscle strength when compared with CA, but a small gain in the peak VO2. An increase in the peak VO2 can be obtained with FES as compared with the control group. Thus, FES may be an alternative in relation with CA for patients with CHF and with those who are unable to perform this kind of exercise.

1 December 2016 in Physiotherapy
Verified
Journal Article
Closed access
CMC.N. Martins
C.N. Martins
MMM.B. Moraes
M.B. Moraes
MHM. Hauck
M. Hauck
LGL.F. Guerreiro
L.F. Guerreiro
DRD.D. Rossato
D.D. Rossato
LSL.U. Signori
L.U. Signori